文献速递临床试验与 GCP流行病学与生物统计

左甲状腺素对亚临床甲减合并急性心梗患者左室射血分数的影响:随机临床试验

Effect of Levothyroxine on Left Ventricular Ejection Fraction in Patients With Subclinical Hypothyroidism and Acute Myocardial Infarction: A Randomized Clinical Trial.
PubMed 文献 · JAMA · 2020-01-01

该双盲随机临床试验纳入95例亚临床甲减合并急性心肌梗死患者,比较左甲状腺素与安慰剂治疗52周对左室射血分数的影响。结果显示两组左室射血分数调整后差异为0.76%(95%CI -0.93%至2.46%;结论不支持对急性心梗合并亚临床甲减患者使用左甲状腺素治疗。

要点

  • 左甲状腺素未显著改善急性心梗合并亚临床甲减患者的左室射血分数。
  • 6项次要结局及心血管不良事件在两组间均无显著差异。

核心结论

  • 在亚临床甲减合并急性心肌梗死患者中,左甲状腺素治疗52周未显著改善左室射血分数,不支持对该人群常规治疗亚临床甲减。

研究设计与样本

  • 共随机95例急性心肌梗死(含ST段抬高型和非ST段抬高型)合并亚临床甲减患者,左甲状腺素组46例,安慰剂组49例。
  • 左甲状腺素起始25µg,滴定至血清促甲状腺激素0.4-2.5 mU/L,每日一次胶囊口服,持续52周。

主要发现

  • 6项次要结局(左室容积、梗死面积、不良事件、健康状态、健康相关生活质量、抑郁)两组间均无显著差异。
  • 心血管不良事件左甲状腺素组15例(33.3%),安慰剂组18例(36.7%)。

关键数值与推荐

  • 主要结局为52周时磁共振成像评估的左室射血分数,调整年龄、性别、心梗类型、受累冠脉区域及基线左室射血分数。
  • 纳入患者中位血清促甲状腺激素5.7 mU/L(四分位距4.8-7.3 mU/L),平均游离甲状腺素1.14 ng/dL(SD 0.16)。
  • 95例随机患者平均年龄63.5岁(SD 9.5),男性72例(76.6%),ST段抬高型心梗65例(69.1%)。
  • 52周主要结局数据可得85例(89.5%)。

临床怎么用

  • 对于急性心肌梗死合并亚临床甲减患者,本研究结果不支持常规使用左甲状腺素治疗亚临床甲减。
  • 临床决策时应结合个体情况,不宜仅基于亚临床甲减诊断即启动左甲状腺素治疗。

局限性

  • 本研究为初步研究,样本量较小(95例),可能不足以检测微小差异。
  • 梗死面积仅在亚组(n=60)中评估。
  • 52周主要结局数据在85例(89.5%)中可得,存在失访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Thyroid hormones play a key role in modulating myocardial contractility. Subclinical hypothyroidism in patients with acute myocardial infarction is associated with poor prognosis. OBJECTIVE: To evaluate the effect of levothyroxine treatment on left ventricular function in patients with acute myocardial infarction and subclinical hypothyroidism. DESIGN, SETTING, AND PARTICIPANTS: A double-blind, randomized clinical trial conducted in 6 hospitals in the United Kingdom. Patients with acute myocardial infarction including ST-segment elevation and non-ST-segment elevation were recruited between February 2015 and December 2016, with the last participant being followed up in December 2017. INTERVENTIONS: Levothyroxine treatment (n = 46) commencing at 25 µg titrated to aim for serum thyrotropin levels between 0.4 and 2.5 mU/L or identical placebo (n = 49), both provided in capsule form, once daily for 52 weeks. MAIN OUTCOMES AND MEASURES: The primary outcome measure was left ventricular ejection fraction at 52 weeks, assessed by magnetic resonance imaging, adjusted for age, sex, type of acute myocardial infarction, affected coronary artery territory, and baseline left ventricular ejection fraction. Secondary measures were left ventricular volumes, infarct size (assessed in a subgroup [n = 60]), adverse events, and patient-reported outcome measures of health status, health-related quality of life, and depression. RESULTS: Among the 95 participants randomized, the mean (SD) age was 63.5 (9.5) years, 72 (76.6%) were men, and 65 (69.1%) had ST-segment elevation myocardial infarction. The median serum thyrotropin level was 5.7 mU/L (interquartile range, 4.8-7.3 mU/L) and the mean (SD) free thyroxine level was 1.14 (0.16) ng/dL. The primary outcome measurements at 52 weeks were available in 85 patients (89.5%). The mean left ventricular ejection fraction at baseline and at 52 weeks was 51.3% and 53.8%, respectively, in the levothyroxine group compared with 54.0% and 56.1%, respectively, in the placebo group (adjusted difference in groups, 0.76% [95% CI, -0.93% to 2.46%]; P = .37). None of the 6 secondary outcomes showed a significant difference between the levothyroxine and placebo treatment groups. There were 15 (33.3%) and 18 (36.7%) cardiovascular adverse events in the levothyroxine and placebo groups, respectively. CONCLUSIONS AND RELEVANCE: In this preliminary study involving patients with subclinical hypothyroidism and acute myocardial infarction, treatment with levothyroxine, compared with placebo, did not significantly improve left ventricular ejection fraction after 52 weeks. These findings do not support treatment of subclinical hypothyroidism in patients with acute myocardial infarction. TRIAL REGISTRATION: isrctn.org Identifier: http://www.isrctn.com/ISRCTN52505169.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Jabbar A, Ingoe L, Junejo S, et al. Effect of Levothyroxine on Left Ventricular Ejection Fraction in Patients With Subclinical Hypothyroidism and Acute Myocardial Infarction: A Randomized Clinical Trial. JAMA. 2020. PMID: 32692386. doi:10.1001/jama.2020.9389

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。